Summary : As the COVID-19 pandemic continues to claim lives around the world, dairy scientists may have a surprising role to play.…
project
-
-
RegulatoryU.S FDA
Aquestive Therapeutics Presented Positive Topline Phase 1 Results for AQST-109 Epinephrine Oral Film at American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
by adminby adminSummary : Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to solve patients’ problems with current standards of care and…
-
Zero Discrimination Day is an observance marked annually on March 1 by United Nations among other international organisations to promote equality and…
-
Summary – Takeda and Code Biotherapeutics announced a collaboration agreement to leverage the latter’s proprietary targeted 3DNA® non-viral genetic medicine delivery platform…
-
Summary – Of course, Xiaomi is not far behind, they too have similar offerings (and they have smart shoes) and the latest…
-
Covid DrugsWHO
EU countries agree to admit travellers vaccinated with WHO-approved Covid shots
by adminby adminSummary : European Union countries agreed on Tuesday to open their borders to travellers from outside the bloc who have had shots…
-
GskLaunch
GSK announces independent Consumer Healthcare company is to be called Haleon
by adminby adminSynopsis : GlaxoSmithKline plc (GSK) today announced that the new company, to result from the proposed demerger of Consumer Healthcare from GSK…
-
Global MarketMerger / Acquisition
Tesis Biosciences Acquires Genome Explorations to Accelerate Clinical Research and Product Development for Chronic Disease Cures
by adminby adminSynopsis: Tesis Biosciences, the leader in targeted genetic sequencing, has acquired Genome Explorations, a premier research institution providing global genomic profiling and…
-
Global MarketPharma Science & Research
Recipharm expands its advanced therapy medicinal products (ATMPs) offering into Virotherapies with the acquisition of Vibalogics
by adminby adminSummary : Recipharm, a global contract development and manufacturing organisation (CDMO), is continuing to build its service offerings in new biologic modalities…
-
Global MarketMerger / Acquisition
Recipharm acquires Arranta Bio, a CDMO leader in advanced therapy medicinal products (ATMPs), to expand its biologics offering in the US
by adminby adminSynopsis : Recipharm, a leading global contract development and manufacturing organisation (CDMO), announced the acquisition of Arranta Bio, a prominent advanced therapy…